PSF biotech collaboration on structure-based drug design with ALTANA Pharma AG
PSF biotech announced that they have extended their pre-existing research collaboration in the field of structure-based drug design with ALTANA Pharma AG. PSF expresses ALTANA Pharma's target proteins and co-crystallizes them with ALTANA Pharma's own ligands. The structural elucidation of these proteins in complex with ligands allows for rapid optimization of active substances by computational approaches and for design of new and innovative drugs. Financial terms of the agreement were not disclosed.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.